Evidence map›Paper›PMID 35919372›Full record

ArticleRSC advances2022

ALD based nanostructured zinc oxide coated antiviral silk fabric.

Udit Kumar, Candace R Fox, Corbin Feit, Elayaraja Kolanthai, Jeremy Sheiber, Yifei Fu, Sushant Singh, Parag Banerjee, Griffith D Parks, Sudipta Seal

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in RSC advances, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Udit KumarAdvanced Materials Processing and Analysis Center, Department of Materials Science and Engineering, University of Central Florida Engineering 1 Rm 207, 12800 Pegasus Dr Orlando FL 32816 USA Sudipta.seal@ucf.edu.ORCID https://orcid.org/0000-0001-5216-8970
Candace R FoxBurnett School of Biomedical Sciences, College of Medicine, University of Central Florida Orlando FL 32827 USA.
Corbin FeitDepartment of Materials Science and Engineering, University of Central Florida Orlando FL 32816 USA.
Elayaraja KolanthaiAdvanced Materials Processing and Analysis Center, Department of Materials Science and Engineering, University of Central Florida Engineering 1 Rm 207, 12800 Pegasus Dr Orlando FL 32816 USA Sudipta.seal@ucf.edu.ORCID https://orcid.org/0000-0003-2615-6866
Jeremy SheiberBurnett School of Biomedical Sciences, College of Medicine, University of Central Florida Orlando FL 32827 USA.ORCID https://orcid.org/0000-0001-8203-0833
Yifei FuAdvanced Materials Processing and Analysis Center, Department of Materials Science and Engineering, University of Central Florida Engineering 1 Rm 207, 12800 Pegasus Dr Orlando FL 32816 USA Sudipta.seal@ucf.edu.
Sushant SinghAmity Institute of Biotechnology, Amity University Chhattisgarh Raipur-493225 C.G India.ORCID https://orcid.org/0000-0002-0858-4405
Parag BanerjeeDepartment of Materials Science and Engineering, University of Central Florida Orlando FL 32816 USA.ORCID https://orcid.org/0000-0003-0401-8155
Griffith D ParksBurnett School of Biomedical Sciences, College of Medicine, University of Central Florida Orlando FL 32827 USA.
Sudipta SealAdvanced Materials Processing and Analysis Center, Department of Materials Science and Engineering, University of Central Florida Engineering 1 Rm 207, 12800 Pegasus Dr Orlando FL 32816 USA Sudipta.seal@ucf.edu.ORCID https://orcid.org/0000-0002-0963-3344

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The COVID-19 pandemic has underscored the importance of research and development in maintaining public health. Facing unprecedented challenges, the scientific community developed antiviral drugs, virucides, and vaccines to combat the infection within the past two years. However, an ever-increasing list of highly infectious SARS-CoV-2 variants (gamma, delta, omicron, and now ba.2 stealth) has exacerbated the problem: again raising the issues of infection prevention strategies and the efficacy of personal protective equipment (PPE). Against this backdrop, we report an antimicrobial fabric for PPE applications. We have fabricated a nanofibrous silk-PEO material using electrospinning followed by zinc oxide thin film deposition by employing the atomic layer deposition technique. The composite fabric has shown 85% more antibacterial activity than the control fabric and was found to possess substantial superoxide dismutase-mimetic activity. The composite was further subjected to antiviral testing using two different respiratory tract viruses: coronavirus (OC43: enveloped) and rhinovirus (RV14: non-enveloped). We report a 95% reduction in infectious virus for both OC43 and RV14 from an initial load of ∼1 × 10

Identifiers

PMID35919372
PMCPMC9251734

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.